The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Dr. William Maguire discussing regulatory considerations related to PSMA PET imaging in clinical trials.

The 2026 PSMA & Beyond conference featured a targeting the cell surface session and presentation by Dr. Rahul Aggarwal discussing DLL3 and whether target expression determines the method of targeting.

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...

AI enhanced MRI improves prostate cancer detection accuracy, outperforming traditional methods and supporting better diagnosis.

Radiopharm Theranostics Ltd (ASX:RAD, OTC:RDPTF, NASDAQ:RADX) has dosed the first patient in a Phase 1 clinical trial of its ...

A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...

Advances Clinical Pipeline Across Dermatology, Urology, Oncology and strengthens Capital Base to support Phase 2 Programs ...

Ibex Medical Analytics (Ibex), the global leader in clinical-grade AI-powered pathology, today announced the launch of Ibex 4, its next-generation platform. Built on Ibex's clinic ...

Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow ...

The cast of Emmerdale have spoken out following tonight's huge episode in which Cain Dingle revealed the truth to his wife Moira about his cancer diagnosis. Viewers know that Cain was recently ...

Plastics contributed 3.4 percent of global greenhouse emissions in 2019, the report said - Copyright AFP/File Peter PARKS Plastics contributed 3.4 percent of global ...

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that returned after radiotherapy. Matched analyses estimated 10-year ...